IJCS | Volume 32, Nº2, March/April 2019

157 22. Ho CY, López B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010;363(6):552-63. 23. Kim JB, Porreca GJ, Song L, Greenway SC, Gorham JM, Church GM, et al. Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science 2007;316(5830):1481-4. 24. Hu DJ, Xu J, Du W, Zhang JX, Zhong M, Zhou YN. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients. Int J Cardiovasc Imaging. 2016 Dec;32(12):1725-1733. Antunes et al. Galectin-3, myocardial fibrosis and hypertrophic cardiomyopathy Int J Cardiovasc Sci. 2019;32(2)152-157 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License